Andrew earned a Ph.D. in Microbiology from New York University School of Medicine, where his studies focused on DNA recombination and repair pathways in microbial pathogens.
Andrew’s later post-doctoral research work at Duke University included design and development of next-generation sequencing techniques to investigate translation regulation during the cellular stress response. While at Duke, Andrew also worked as a Technology Transfer Fellow in the Office of Licensing and Ventures.
Andrew assists clients with the preparation and prosecution of patent applications relating to biotechnology and pharmaceutical inventions, including targeted gene-editing techniques, enzyme engineering, biologics and antibodies, sequencing methods and diagnostic biomarkers.
In The Press